SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Ealixir, Inc. (EAXR) trades at a trailing P/E of 1,000.0. Trailing earnings yield is 0.10%.
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 1,000.0); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY 0.10%).
- Trailing Earnings Yield 0.10% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
Overall SharesGrow Score: 28/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — EAXR
Valuation Multiples
P/E (TTM)1,000.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio26.61
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.06
FCF / Share$0.00
Yields & Fair Value
Earnings Yield0.10%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2010 |
$-8,639.86 |
$34.06M |
$-28.87M |
-84.7% |
| 2011 |
$-183.48 |
$15.79M |
$-10.66M |
-67.5% |
| 2012 |
$-0.41 |
$10.75M |
$-307.02K |
-2.9% |
| 2018 |
$-3,581,650.00 |
$963.54K |
$-329.51K |
-34.2% |
| 2019 |
$-95.25 |
$1.32M |
$-1.33M |
-101.1% |
| 2020 |
$-0.01 |
$1.67M |
$-520.64K |
-31.2% |
| 2021 |
$-0.01 |
$3.54M |
$-334.96K |
-9.5% |
| 2022 |
$0.00 |
$4.14M |
$139.77K |
3.4% |
| 2023 |
$-0.01 |
$5.05M |
$-1.19M |
-23.5% |
| 2024 |
$0.00 |
$3.62M |
$95.73K |
2.6% |
